Literature DB >> 12707343

A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo.

Toshiaki Ara1, Manami Itoi, Kenji Kawabata, Takeshi Egawa, Koji Tokoyoda, Tatsuki Sugiyama, Nobutaka Fujii, Takashi Amagai, Takashi Nagasawa.   

Abstract

The functions of a chemokine CXC chemokine ligand (CXCL) 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its physiologic receptor CXCR4 in T cell development are controversial. In this study, we have genetically further characterized their roles in fetal and adult T cell development using mutant and chimeric mice. In CXCL12(-/-) or CXCR4(-/-) embryos on a C57BL/6 background, accumulation of T cell progenitors in the outer mesenchymal layer of the thymus anlage during initial colonization of the fetal thymus was comparable with that seen in wild-type embryos. However, the expansion of CD3(-)CD4(-)CD8(-) triple-negative T cell precursors at the CD44(-)CD25(+) and CD44(-)CD25(-) stages, and CD4(+)CD8(+) double-positive thymocytes was affected during embryogenesis in these mutants. In radiation chimeras competitively repopulated with CXCR4(-/-) fetal liver cells, the reduction in donor-derived thymocytes compared with wild-type chimeras was much more severe than the reduction in donor-derived myeloid lineage cells in bone marrow. Triple negative CD44(+)CD25(+) T cell precursors exhibited survival response to CXCL12 in the presence of stem cell factor as well as migratory response to CXCL12. Thus, it may be that CXCL12 and CXCR4 are involved in the expansion of T cell precursors in both fetal and adult thymus in vivo. Finally, enforced expression of bcl-2 did not rescue impaired T cell development in CXCR4(-/-) embryos or impaired reconstitution of CXCR4(-/-) thymocytes in competitively repopulated mice, suggesting that defects in T cell development caused by CXCR4 mutation are not caused by reduced expression of bcl-2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707343     DOI: 10.4049/jimmunol.170.9.4649

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

Review 1.  Thymic stromal cell subsets for T cell development.

Authors:  Takeshi Nitta; Harumi Suzuki
Journal:  Cell Mol Life Sci       Date:  2016-01-29       Impact factor: 9.261

Review 2.  Chemokine control of lymphocyte trafficking: a general overview.

Authors:  Jens V Stein; César Nombela-Arrieta
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 3.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus.

Authors:  M Lucila Scimone; Iannis Aifantis; Irina Apostolou; Harald von Boehmer; Ulrich H von Andrian
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

Review 5.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

6.  Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12.

Authors:  Yedidya Saiman; Tatsuki Sugiyama; Noa Simchoni; Carlo Spirli; Meena B Bansal
Journal:  Am J Pathol       Date:  2015-04-29       Impact factor: 4.307

7.  Distinct changes in adult lymphopoiesis in Rag2-/- mice fully reconstituted by alpha4-deficient adult bone marrow cells.

Authors:  Ena R Banerjee; Yvette E Latchman; Yi Jiang; Greg V Priestley; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2008-05-12       Impact factor: 3.084

Review 8.  T and B lymphocyte differentiation from hematopoietic stem cell.

Authors:  Anne Y Lai; Motonari Kondo
Journal:  Semin Immunol       Date:  2008-06-25       Impact factor: 11.130

Review 9.  Regulation of hematopoietic stem cells by bone marrow stromal cells.

Authors:  Bryan A Anthony; Daniel C Link
Journal:  Trends Immunol       Date:  2013-11-05       Impact factor: 16.687

10.  Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

Authors:  Zhihong Zeng; Yue Xi Shi; Ismael J Samudio; Rui-Yu Wang; Xiaoyang Ling; Olga Frolova; Mark Levis; Joshua B Rubin; Robert R Negrin; Elihu H Estey; Sergej Konoplev; Michael Andreeff; Marina Konopleva
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.